scholarly journals A phase I open-label study evaluating the cardiovascular safety of sorafenib in patients with advanced cancer

2010 ◽  
Vol 67 (4) ◽  
pp. 751-764 ◽  
Author(s):  
Anthony W. Tolcher ◽  
Leonard J. Appleman ◽  
Geoffrey I. Shapiro ◽  
Alain C. Mita ◽  
Frank Cihon ◽  
...  
Keyword(s):  
Phase I ◽  
Advanced Cancer ◽  
Cardiovascular Safety ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

A phase I open-label study investigating the disposition of [14C]-cabazitaxel in patients with advanced solid tumors

2015 ◽  
Vol 26 (3) ◽  
pp. 350-358 ◽  
Author(s):  
Laurence Ridoux ◽  
Dorothée R. Sémiond ◽  
Carine Vincent ◽  
Hélène Fontaine ◽  
Christine Mauriac ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Advanced Solid Tumors ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

A phase I, open-label study of the safety, tolerability and pharmacokinetics of lapatinib (GW572016) in combination with letrozole in cancer patients

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 3001-3001 ◽  
Author(s):  
Q. Chu ◽  
L. Goldstein ◽  
N. Murray ◽  
E. Rowinsky ◽  
M. Cianfrocca ◽  
...  
Keyword(s):  
Phase I ◽  
Cancer Patients ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

Low-dose levomepromazine in refractory emesis in advanced cancer patients: an open-label study

2005 ◽  
Vol 19 (1) ◽  
pp. 71-75 ◽  
Author(s):  
Jorge H Eisenchlas ◽  
Nicolás Garrigue ◽  
Marta Junin ◽  
Gustavo G De Simone
Keyword(s):  
Cancer Patients ◽  
Advanced Cancer ◽  
Low Dose ◽  
Advanced Cancer Patients ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Refractory Emesis
Sign in / Sign up

Export Citation Format

Share Document